Medicine for treating mastitis and preparation method of medicine

The invention discloses a medicine for treating mastitis. The medicine is characterized by containing 4-amino-5-methyl-2-[1-(3,3,4,4,4-pentafluorobutyl)imidazo[1,5-a]pyridine-3-yl]-5-phenyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidine-6-one or a pharmaceutically accelerable salt and one or more pharmaceu...

Full description

Saved in:
Bibliographic Details
Main Authors LIU LILI, YUAN YAOWEI, JIANG QIANQIAN, XU FANG
Format Patent
LanguageChinese
English
Published 31.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses a medicine for treating mastitis. The medicine is characterized by containing 4-amino-5-methyl-2-[1-(3,3,4,4,4-pentafluorobutyl)imidazo[1,5-a]pyridine-3-yl]-5-phenyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidine-6-one or a pharmaceutically accelerable salt and one or more pharmaceutically accelerable carriers. The invention further relates to a preparation method of the medicineand application of the medicine in preparation of a medicine for treating the mastitis, particularly acute mastitis, more particularly acute mastitis caused by bacterial infection. 本发明公开了一种治疗乳腺炎的药物,其特征在于所述药物包含4-氨基-5-甲基-2-[1-(3,3,4,4,4-五氟丁基)咪唑并[1,5-a]吡啶-3-基]-5-苯基-5,7-二氢-6H-吡咯并[2,3-d]嘧啶-6-酮或其药学上可接受的盐和一种或多种药学上可接受的载体。本发明还涉及所述药物的制备方法以及所述药物在制备用于治疗乳腺炎,特别是急性乳腺炎,更特别是细菌感染引起的急性乳腺炎的药物中的用途。
Bibliography:Application Number: CN202010312547